| P50 | author | Pierre-Julien Viailly | Q56939796 |
| P2093 | author name string | Philippe Bertrand | |
| | Fabrice Jardin | |
| | Hervé Tilly | |
| | Thierry Frebourg | |
| | Philippe Ruminy | |
| | Pierre Vera | |
| | Vincent Camus | |
| | Christian Bastard | |
| | Aspasia Stamatoullas | |
| | Sydney Dubois | |
| | Stéphanie Becker | |
| | Catherine Maingonnat | |
| | Elodie Bohers | |
| | Nasrin Sarafan-Vasseur | |
| | Valérie Tallon-Simon | |
| | Marie Cornic | |
| | Jean Michel Picquenot | |
| | Sylvain Mareschal | |
| | Liana Veresezan | |
| P2860 | cites work | Liquid biopsies: genotyping circulating tumor DNA | Q27010159 |
| | Selective inhibitors of nuclear export show that CRM1/XPO1 is a target in chronic lymphocytic leukemia | Q27674083 |
| | Cancer statistics, 2015 | Q27860576 |
| | Serum CD163 and TARC as disease response biomarkers in classical Hodgkin lymphoma | Q28281028 |
| | Genomic and molecular characterization of esophageal squamous cell carcinoma | Q28657686 |
| | Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia | Q29614659 |
| | Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation | Q33236181 |
| | Recurrent mutations of the STAT6 DNA binding domain in primary mediastinal B-cell lymphoma. | Q33669371 |
| | Molecular karyotypes of Hodgkin and Reed-Sternberg cells at disease onset reveal distinct copy number alterations in chemosensitive versus refractory Hodgkin lymphoma | Q33840504 |
| | Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma. | Q34112913 |
| | A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease | Q34480381 |
| | Classical Hodgkin lymphoma is characterized by recurrent copy number gains of the short arm of chromosome 2. | Q34520814 |
| | Hodgkin lymphoma | Q34643277 |
| | Treatment of Hodgkin lymphoma: a 50-year perspective | Q34659109 |
| | Limit of blank, limit of detection and limit of quantitation | Q34852018 |
| | The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications | Q35029409 |
| | Part II: Hodgkin's lymphoma--diagnosis and treatment | Q35618783 |
| | Cell-free DNA levels in plasma of patients with non-small-cell lung cancer and inflammatory lung disease | Q35909641 |
| | Immunohistochemical and genomic profiles of diffuse large B-cell lymphomas: implications for targeted EZH2 inhibitor therapy? | Q36140942 |
| | Recurrent somatic loss of TNFRSF14 in classical Hodgkin lymphoma | Q36463861 |
| | Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American cooperative group trial. | Q36814594 |
| | STAT6-mediated BCL6 repression in primary mediastinal B-cell lymphoma (PMBL). | Q37138531 |
| | The clinical utilization of circulating cell free DNA (CCFDNA) in blood of cancer patients | Q37225239 |
| | Pathogenesis of classical and lymphocyte-predominant Hodgkin lymphoma | Q37463052 |
| | KPT-330 inhibitor of CRM1 (XPO1)-mediated nuclear export has selective anti-leukaemic activity in preclinical models of T-cell acute lymphoblastic leukaemia and acute myeloid leukaemia. | Q37693609 |
| | The molecular pathogenesis of primary mediastinal large B-cell lymphoma | Q37893841 |
| | Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B-cell lymphoma | Q38764010 |
| | Non-invasive detection of genomic imbalances in Hodgkin/Reed-Sternberg cells in early and advanced stage Hodgkin's lymphoma by sequencing of circulating cell-free DNA: a technical proof-of-principle study | Q38929950 |
| | Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells. | Q38930717 |
| | Selective JAK2 inhibition specifically decreases Hodgkin lymphoma and mediastinal large B-cell lymphoma growth in vitro and in vivo | Q39017147 |
| | Detection of classical Hodgkin lymphoma specific sequence in peripheral blood using a next-generation sequencing approach | Q39024241 |
| | FOXO1 is a tumor suppressor in classical Hodgkin lymphoma. | Q39394904 |
| | Mutations in the genes coding for the NF-κB regulating factors IκBα and A20 are uncommon in nodular lymphocyte-predominant Hodgkin's lymphoma | Q39817963 |
| | Digital PCR for quantification of recurrent and potentially actionable somatic mutations in circulating free DNA from patients with diffuse large B-cell lymphoma | Q40353159 |
| | Identification of a nuclear export sequence in the MHC CIITA. | Q40967326 |
| | Somatic mutations of cell-free circulating DNA detected by next-generation sequencing reflect the genetic changes in both germinal center B-cell-like and activated B-cell-like diffuse large B-cell lymphomas at the time of diagnosis | Q42384499 |
| | Cryptic XPO1-MLLT10 translocation is associated with HOXA locus deregulation in T-ALL. | Q42986380 |
| | FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma. | Q46693607 |
| | Revised response criteria for malignant lymphoma | Q47582438 |
| | SF3B1 mutations correlated to cytogenetics and mutations in NOTCH1, FBXW7, MYD88, XPO1 and TP53 in 1160 untreated CLL patients. | Q52644149 |
| | Presence of multiple recurrent mutations confers poor trial outcome of relapsed/refractory CLL. | Q52836237 |
| | Next-Generation Sequencing in Diffuse Large B-Cell Lymphoma Highlights Molecular Divergence and Therapeutic Opportunities: a LYSA Study. | Q52887085 |
| | The mutational landscape of Hodgkin lymphoma cell lines determined by whole-exome sequencing | Q57272139 |
| | Whole exome sequencing of relapsed/refractory patients expands the repertoire of somatic mutations in diffuse large B-cell lymphoma | Q61053563 |
| | Plasma DNA microsatellite panel as sensitive and tumor‐specific marker in lung cancer patients | Q73294049 |
| | Mediastinal gray zone lymphoma: the missing link between classic Hodgkin's lymphoma and mediastinal large B-cell lymphoma | Q81349866 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1094-1101 | |
| P577 | publication date | 2016-06-13 | |
| P1433 | published in | Haematologica | Q5638209 |
| P1476 | title | Detection and prognostic value of recurrent exportin 1 mutations in tumor and cell-free circulating DNA of patients with classical Hodgkin lymphoma | |
| P478 | volume | 101 | |